MICA-α3 and NKG2Dexpression andantibody bindingfunctional analysis
No.1 Reaseach Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai 200051, China
Online published: 2025-08-16
Supported by
Capacity Building Project of Shanghai Enterprise Technology Center(Shanghai Innovation-J-08-25)
目的 重组表达人MHC Ⅰ类链相关蛋白A α3结构域(MHCⅠchain related protein A α3 domain,MICA-α3)蛋白及自然杀伤细胞受体2D(natural killer group 2D,NKG2D)蛋白,制备抗MICA-α3单克隆抗体,并检测其结合功能。方法 构建MICA-α3及NKG2D蛋白表达载体,经转化大肠埃希菌BL21菌株表达重组蛋白,通过分子筛、组氨酸标签蛋白层析纯化。用重组MICA-α3蛋白免疫小鼠,采用杂交瘤技术筛选单克隆抗体,用细胞ELISA检测单克隆抗体功能。结果 重组蛋白在大肠埃希菌BL21菌株中以包涵体形式表达。筛选得到5株能和表达MICA-α3的MDA-MB-453细胞结合的单克隆抗体,且不影响MDA-MB-453细胞与NKG2D结合。结论 制备的抗MICA-α3单克隆抗体能与肿瘤细胞结合,同时不影响肿瘤细胞与NKG2D结合。
Lu Jin , Liang Hongyuan , Wu Lina , Qu Aidong . MICA-α3和NKG2D蛋白的表达及其抗体结合功能检测[J]. 国际生物制品学杂志, 2022 , 45(1) : 47 -51 . DOI: 10.3760/cma.j.cn 311962-20210108-00003
Objective To express recombinant human MHCⅠchain related protein A α3 domain (MICA-α3) and natural killer group 2D (NKG2D), prepare anti-MICA-α3 monoclonal antibodies and test antibody binding function. Methods MICA-α3 and NKG2D expression vectors MICA-α3-pET11c and NKG2D-pET16b were constructed and transformed into BL21 for expression. Recombinant proteins were purified by polyhistidine-tag chromatography and gel chromatography. After immunizing mice with MICA-α3 protein and screening monoclonal antibody by hybridoma technology, the monoclonal antibody function was tested by cell-ELISA. Results Recombinant proteins were expressed in the form of inclusion body in E.coli BL21. Five monoclonal antibodys were screened, which could bind to MDA-MB-453 cells espressing MICA-α3,and this binding did not affect the binding of MDA-MB-453 cells to NKG2D. Conclusion Anti MICA-α3 monoclonal antibody can bind to tumor cells without affecting the binding of tumor cells to NKG2D.
/
| 〈 |
|
〉 |